Chikafumi Yokoyama
President at REPROCELL INCORPORATED
Net worth: 1 M $ as of 2024-03-30
Profile
Chikafumi Yokoyama is currently the Chairman at BioServe Biotechnologies Ltd., Biopta Ltd., ReproCELL USA, Inc., Stemgent, Inc., ReproCELL Europe Ltd., RC Partners, Inc., Repro Curato KK, and MAGiQ Therapeutics KK.
He is also the President & Representative Director at ReproCELL, Inc. Dr. Yokoyama previously served as Chairman at Asterand Biosciences, Inc. and Reinnervate Ltd.
He obtained a doctorate degree from the University of Tokyo in 1996 and also completed his undergraduate studies at the University of Tokyo.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
REPROCELL INC.
1.15% | 2023-09-29 | 1,016,950 ( 1.15% ) | 1 M $ | 2024-03-30 |
Chikafumi Yokoyama active positions
Companies | Position | Start |
---|---|---|
REPROCELL INCORPORATED | President | 2005-10-31 |
ReproCELL USA, Inc.
ReproCELL USA, Inc. Medical/Nursing ServicesHealth Services ReproCELL USA, Inc. is based in Beltsville, MD. Part of ReproCELL, Inc., ReproCELL USA, Inc. is a company that engages in iPS cell research business. | Chairman | 2016-08-31 |
BioServe Biotechnologies Ltd.
BioServe Biotechnologies Ltd. BiotechnologyHealth Technology BioServe Biotechnologies Ltd. provides genomics products and services. It offers DNA, RNA extractions, genotyping, real time PCR and molecular diagnostic testing services. The company was founded by Ramakrishna Modali and Robert Skurla in 1989 and is headquartered in Beltsville, MD. | Chairman | 2014-08-31 |
RC Partners, Inc.
RC Partners, Inc. Investment ManagersFinance RC Partners, Inc. engages in the operation and management of investment funds. The company was founded on February 12, 2014 and is headquartered in Yokohama, Japan. | Director/Board Member | 2014-01-31 |
Stemgent, Inc. /New/
Stemgent, Inc. /New/ BiotechnologyHealth Technology Stemgent, Inc. develops technology and application solutions for the advancement of stem cell research. The company was founded in 2008 and is headquartered in Lexington, MA. | Chairman | 2014-09-30 |
Biopta Ltd.
Biopta Ltd. Miscellaneous Commercial ServicesCommercial Services Biopta Ltd. provides biological research and human tissues in drug development. It conducts research on the effect of drug activity prior to clinical trials using fresh human tissues. The firm engages in the use of functional human tissue to predict drug activity prior to clinical trials. It provides lab services, comparative pharmacology, clinical biopsies, in vitro and ex vivo techniques, and customized services, as well as cardiac, vascular, respiratory, gastrointestinal, human absorption, skin, and genitourinary related services. The company was founded by David Bunton and Chris Hillier and in 2002 and is headquartered in Glasgow, the United Kingdom. | Chairman | 2015-10-31 |
ReproCELL Europe Ltd.
ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ReproCELL, Inc., ReproCELL Europe Ltd. is a British company that specializes in providing solutions for translating scientific discoveries into therapies. The private company is based in Glasgow, UK. The company's expertise lies in human tissue and stem cells, and they offer consultation services to researchers facing challenges in their research. David C. Bunton has been the CEO of the company since 2017. | Chairman | 2016-06-30 |
Repro Curato KK
Repro Curato KK Medical DistributorsDistribution Services Part of Curato Japan KK, Repro Curato KK is a Japanese company that distributes cosmetics, hair materials, and beauty products. The private company is based in Tokyo, Japan. The company was founded in 2016. Repro Curato KK was acquired by Curato Japan KK on July 16, 2021. | Director/Board Member | 2016-10-31 |
MAGiQ Therapeutics KK | Director/Board Member | 2019-05-31 |
Former positions of Chikafumi Yokoyama
Companies | Position | End |
---|---|---|
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Training of Chikafumi Yokoyama
University of Tokyo | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 11 |
---|---|
Asterand Biosciences, Inc.
Asterand Biosciences, Inc. BiotechnologyHealth Technology Asterand Biosciences, Inc. provided stem cell research products. It offered proprietary reagents and tools developed by stem cell scientists. The firm's products included small molecules for pluripotency, self-renewal and differentiation, viral-delivered transcription factors, matrices, cell lines, cytokines, antibodies and transfection reagents. The company was founded by Ian W. Ratcliffe, Stephen M. Chang and Sheng Ding in 2006 and headquartered in Detroit, MI. | Health Technology |
BioServe Biotechnologies Ltd.
BioServe Biotechnologies Ltd. BiotechnologyHealth Technology BioServe Biotechnologies Ltd. provides genomics products and services. It offers DNA, RNA extractions, genotyping, real time PCR and molecular diagnostic testing services. The company was founded by Ramakrishna Modali and Robert Skurla in 1989 and is headquartered in Beltsville, MD. | Health Technology |
Biopta Ltd.
Biopta Ltd. Miscellaneous Commercial ServicesCommercial Services Biopta Ltd. provides biological research and human tissues in drug development. It conducts research on the effect of drug activity prior to clinical trials using fresh human tissues. The firm engages in the use of functional human tissue to predict drug activity prior to clinical trials. It provides lab services, comparative pharmacology, clinical biopsies, in vitro and ex vivo techniques, and customized services, as well as cardiac, vascular, respiratory, gastrointestinal, human absorption, skin, and genitourinary related services. The company was founded by David Bunton and Chris Hillier and in 2002 and is headquartered in Glasgow, the United Kingdom. | Commercial Services |
Reinnervate Ltd.
Reinnervate Ltd. BiotechnologyHealth Technology Reinnervate Ltd. operates as a life sciences company that develops, manufactures, and sells products for three dimensional (3D) cell culture applications that include cancer research, drug discovery, HTS, stem cell biology, and others. It offers Alvetex, a porous polystyrene scaffold designed for 3D cell culture. The company was founded by Stefan A. Przyborski in 2002 and is headquartered in Sedgefield, the United Kingdom. | Health Technology |
ReproCELL, Inc. | |
ReproCELL USA, Inc.
ReproCELL USA, Inc. Medical/Nursing ServicesHealth Services ReproCELL USA, Inc. is based in Beltsville, MD. Part of ReproCELL, Inc., ReproCELL USA, Inc. is a company that engages in iPS cell research business. | Health Services |
RC Partners, Inc.
RC Partners, Inc. Investment ManagersFinance RC Partners, Inc. engages in the operation and management of investment funds. The company was founded on February 12, 2014 and is headquartered in Yokohama, Japan. | Finance |
Stemgent, Inc. /New/
Stemgent, Inc. /New/ BiotechnologyHealth Technology Stemgent, Inc. develops technology and application solutions for the advancement of stem cell research. The company was founded in 2008 and is headquartered in Lexington, MA. | Health Technology |
ReproCELL Europe Ltd.
ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ReproCELL, Inc., ReproCELL Europe Ltd. is a British company that specializes in providing solutions for translating scientific discoveries into therapies. The private company is based in Glasgow, UK. The company's expertise lies in human tissue and stem cells, and they offer consultation services to researchers facing challenges in their research. David C. Bunton has been the CEO of the company since 2017. | Commercial Services |
Repro Curato KK
Repro Curato KK Medical DistributorsDistribution Services Part of Curato Japan KK, Repro Curato KK is a Japanese company that distributes cosmetics, hair materials, and beauty products. The private company is based in Tokyo, Japan. The company was founded in 2016. Repro Curato KK was acquired by Curato Japan KK on July 16, 2021. | Distribution Services |
MAGiQ Therapeutics KK |
- Stock Market
- Insiders
- Chikafumi Yokoyama